Frank Stokes
Board Member
Exagen Inc. (XGN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Castle Biosciences Inc (CSTL) | Chief Financial Officer | $488,800 | $880,250 |
| 2022 | Castle Biosciences Inc (CSTL) | Chief Financial Officer | $470,000 | $2,607,073 |
| 2021 | Castle Biosciences Inc (CSTL) | Chief Financial Officer | $450,000 | $2,865,351 |
| 2020 | Castle Biosciences Inc (CSTL) | Chief Financial Officer | $400,000 | $2,217,067 |
| 2019 | Castle Biosciences Inc (CSTL) | Chief Financial Officer | $327,117 | $1,498,232 |
| 2018 | Castle Biosciences Inc (CSTL) | Chief Financial Officer | $275,000 | $593,329 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.